Orphan Indications Pipeline Insights, 2015 - A DelveInsight’s Report

DWARKA, India - Oct. 28, 2015 - PRLog -- Till date, six to seven thousand rare diseases have been discovered and new diseases are regularly described in medical literature. Rare diseases include rare cancers such as childhood cancers, sarcoma and some other well known conditions such as cystic fibrosis, Huntington’s disease, Crohn disease, etc.

Products intended to treat rare diseases are developed to treat patients suffering from very serious diseases for which no treatment, or at least a satisfactory one, has so far been available. The number of rare diseases for which no treatment is currently available is estimated to be between 4,000 and 5,000 worldwide.

The current economic situation plus the huge generic competition shifted the focus of pharmaceutical companies from the essential medicines to the new business model such as orphan drugs. The new business model of orphan drugs could offer an integrated healthcare solution that enables Pharma companies to develop newer areas of therapeutics, diagnosis, treatment, monitoring, and patient support.

DelveInsight’s Reports on Orphan indications provide assessment over advancement in technologies, market trend, partnering & licensing opportunities, pipeline scenario and competitive landscape. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. We also deal custom research services in coherence with interest area of the clients.

DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email at info@delveInsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.